Search

everythinglearnresearchcommunity

for

Search:↓

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

A 22-year-old homosexual man was diagnosed with secondary syphilis, genital warts, and HIV, highlighting the high STI risk in men who have sex with men.

Hair changes are common in AIDS patients and can add to their financial and emotional stress.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Stopping minoxidil caused significant hair loss, but regrowth occurred after resuming use.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Treatment with benzylpenicillin and prednisolone cured the patient's syphilis and hair loss.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

HIV can cause unusual and severe skin problems that are hard to treat.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Itraconazole was effective in treating unusual M. canis infections in only one of two HIV-infected men.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

Women with early onset androgenetic alopecia have worse lipid profiles.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Six African American women experienced hair loss after switching to a new HIV medication.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Dilated pupils can be an early sign of HIV/AIDS.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.